Back to News
May 15, 2026 8:00 PM

Light AI reports Financial Results for Three Months ended March 31, 2026

VANCOUVER, BC, May 15, 2026 /CNW/ - Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB:OHCFF), a digital healthcare technology company specializing in AI health diagnostics, announced its first quarter 2026 financial and operating results for the period ended March 31, 2026. Results are based on the unaudited consolidated financial statements for the three months ended March 31, 2026 and 2025 and MD&A prepared under IFRS, with figures in Canadian dollars unless stated otherwise.

Light AI QuickScan™ Strep A software helps healthcare providers make informed decisions at the point of care, supporting better patient outcomes by guiding lab testing and antibiotic treatment. The company is currently conducting clinical trials and seeking regulatory approval, with plans to launch commercialization in mid 2026.

Financial and Operating Results Summary for the three months ended March 31, 2026  

Summary Operating Results

Q1 2026

Q4 2025

Q1 2025

for three months ended

$

$

$

Research and Development

815,485

809,496

1,217,243

General and Administrative

550,035

422,775

560,138

Share-based Compensation

308,201

932,456

134,305

Marketing and Investor Relations

391,899

112,115

2,411,839

Total operating costs

2,065,620

2,276,842

4,323,525

Interest, amortization and other charges

(3,196)

(20,482)

(43,055)

Net comprehensive loss

2,062,424

2,256,360

4,280,470

Basic and fully diluted Earnings per Share

(0.02)

(0.04)

Weighted average shares outstanding

122,352,735